Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.58% | 5.62% | -40.89% | -14.54% | -45.79% |
| Total Depreciation and Amortization | 0.08% | 44.37% | -32.84% | 69.05% | 34.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.82% | 4.96% | 21.32% | -11.59% | -38.71% |
| Change in Net Operating Assets | -165.53% | 53.12% | -193.36% | 53.36% | -63.69% |
| Cash from Operations | -19.42% | 10.90% | -86.76% | -11.22% | -215.10% |
| Capital Expenditure | 35.38% | 80.31% | 55.68% | -191.93% | -88.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 156.43% | 26.42% | -- | -- | -- |
| Cash from Investing | 155.61% | 27.76% | -1,684.16% | -191.93% | -88.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 463,219.10% | -99.96% | 787.61% | 870.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -338.59% | 117.87% | -- | -- |
| Cash from Financing | 413,086.70% | -100.04% | 801.84% | 855.60% | -- |
| Foreign Exchange rate Adjustments | 292.97% | -9.40% | 43.20% | -146.71% | 651.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,096.31% | -118.82% | 1,709.56% | 200.61% | -143.24% |